Apogee Biotechnology (United States)

Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

Kevin J. French, Yan Zhuang, Lynn W. Maines et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 309 citations · Full text

Antitumor Activity of Sphingosine Kinase Inhibitors

Kevin J. French, John J. Upson, Staci N. Keller et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 239 citations

Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase

Lynn W. Maines, Leo R. Fitzpatrick, Kevin J. French et al. · Digestive Diseases and Sciences · 2007 · 183 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Orally Available Inhibitors +9

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Carolyn D. Britten, Elizabeth Garrett‐Mayer, Steven Chin et al. · Clinical Cancer Research · 2017 · 159 citations · Full text

Two N-Myristoyltransferase Isozymes Play Unique Roles in Protein Myristoylation, Proliferation, and Apoptosis

Charles Ducker, John J. Upson, Kevin J. French et al. · Molecular Cancer Research · 2005 · 113 citations · Full text